Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study
نویسندگان
چکیده
منابع مشابه
Duration of anticoagulant therapy for venous thromboembolism.
The Medical Journal of Australia ISSN: 0025729X 15 June 2009 190 12 659-660 ©The Medical Journal of Australia 2009 www.mja.com.au Editorials days with unfractionated heparin, low-molecular-wei fondaparinux, prevents thrombus progression and re of recurrent VTE and death during the acute ph treatment is continued beyond the acute phase, wa the risk of recurrent VTE but increases the risk of requ...
متن کاملthrombolytic-plus-anticoagulant therapy versus anticoagulant-alone therapy in submassive pulmonary thromboembolism (tvaspe study): a randomized clinical trial
background: the use of thrombolytic agents in the treatment of hemodynamically stable patients with acute submassive pulmonary embolism (pte) remains controversial. we, therefore, conducted this study to compare the effect of thrombolytic plus anticoagulation versus anticoagulation alone on early death and adverse outcome following submassive pte. methods: w e conducted a study of patients with...
متن کاملNew concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism.
Recent trials on secondary prophylaxis after venous thromboembolism (VTE) have provided a wealth of data on the risk factors for recurrence and, to some extent, also for bleeding. Some of the results are consistent across the studies, but there are also conflicting data. Certain risk factors, such as pulmonary embolism versus deep vein thrombosis or presence of cardiolipin antibodies, have a mo...
متن کاملSex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
In patients with venous thromboembolism (VTE), the outcome during the course of anticoagulant therapy may differ according to the patient's sex. We used the RIETE (Registro Informatizado Enfermedad TromboEmbólica) database to compare the rate of VTE recurrences, major bleeding, and mortality due to these events according to sex.As of August 2013, 47,499 patients were enrolled in RIETE, of whom ...
متن کاملThrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial
BACKGROUND The use of thrombolytic agents in the treatment of hemodynamically stable patients with acute submassive pulmonary embolism (PTE) remains controversial. We, therefore, conducted this study to compare the effect of thrombolytic plus anticoagulation versus anticoagulation alone on early death and adverse outcome following submassive PTE. METHODS We conducted a study of patients with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Haematologica
سال: 2019
ISSN: 0390-6078,1592-8721
DOI: 10.3324/haematol.2018.209924